Sunshine Biopharma CFO Camille Sebaaly's 2022 pay jumps 169% to $930K
Sunshine Biopharma reports 2022 executive compensation
By ExecPay News
Published: October 18, 2023
Sunshine Biopharma reported fiscal year 2022 executive compensation information on October 18, 2023.
In 2022, three executives at Sunshine Biopharma received on average a compensation package of $595K, a 46% increase compared to previous year.
Average pay of disclosed executives at Sunshine Biopharma
Camille Sebaaly, Chief Financial Officer, received $930K in total, which increased by 169% compared to 2021. 68% of Sebaaly's compensation, or $630K, was in bonus. Sebaaly also received $300K in salary.
Abderrazzak Merzouki, Chief Operating Officer, received a compensation package of $485K, which increased by 17% compared to previous year. 51% of the compensation package, or $245K, was in bonus.
Steve N. Slilaty, Chief Executive Officer, earned $370K in 2022, a 20% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on October 18, 2023.